By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Diagnostic Hybrids, Inc. 

350 West State Street

Athens  Ohio  45701  U.S.A.
Phone: 740-593-1784 or 800-344-5847 Fax: 740-593-0980


SEARCH JOBS


Key Statistics


Email: info@dhiusa.com
Ownership: Private

Web Site: Diagnostic Hybrids, Inc.
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
InGen BioSciences Announced Comprehensive Offering of in Vitro Diagnostics in France With the Signature of Exclusive Distribution Partnerships With Quidel Corporation (QDEL)and Diagnostic Hybrids, Inc. 8/20/2012 8:07:14 AM
Diagnostic Hybrids, Inc. Receives Approval from Chinese SFDA for D3(R) Ultra(TM) DFA Respiratory Virus Screening and ID Kit 7/1/2010 10:17:23 AM
Diagnostic Hybrids, Inc. Receives FDA Emergency Use Authorization for D3 Ultra 2009 H1N1 Influenza A Virus ID Kit 2/24/2010 7:04:43 AM
Diagnostic Hybrids, Inc. Receives FDA Emergency Use Authorization for D3 Ultra 2009 H1N1 Influenza A Virus ID Kit 2/23/2010 1:06:51 PM
Quidel Corporation (QDEL) Completes Acquisition of Diagnostic Hybrids, Inc. 2/22/2010 10:15:13 AM
Diagnostic Hybrids, Inc. Announces FDA Clearance of D3(R) FastPointTM L-DFA(TM) RSV/MPV Identification Kit 1/12/2010 9:59:34 AM
Quidel Corporation (QDEL) to Buy Diagnostic Hybrids, Inc. for $130 Million 1/11/2010 6:50:00 AM
Diagnostic Hybrids, Inc. Sponsors Graves' Disease Foundation's Patient and Family Education Conference 11/18/2009 8:40:02 AM
Diagnostic Hybrids, Inc. Announces FDA Clearance of D3(R) FastPointTM L-DFATM Influenza A/ Influenza B Virus Identification Kit 10/27/2009 2:33:33 PM
Diagnostic Hybrids, Inc. Announces FDA Clearance of D3(R) FastPointTM L-DFATM Respiratory Virus Identification Kit 9/15/2009 6:56:00 AM
1234
//-->